Limited funding of Herceptin
The Ministry of Health and Long-Term Care
Date:
05/12/2011
The Ministry of Health and Long-Term Care agreed to fund Herceptin for patients with breast cancer tumours of one centimetre in diameter or less. The Ombudsman suspended his investigation in May 2011, but he continues to monitor complaints and developments on the issue.
Related Documents
Annual Report 2010-2011 update
Herceptin coverage extended - Ombudsman suspends investigation: May 12, 2011 (PDF, 262 kB)
Ombudsman to investigate Ontario’s limited funding of Herceptin: March 18, 2011